Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 8:56 PM

Published 11/06/2009 by Mass High Tech


Boston Scientific pays $296M to settle Guidant allegations

Medical device maker plans to spend $296 million to settle a U.S. Justice Department investigation into the companys alleged failure to report possible defibrillator defects.

Natick-based Boston Scientific (NYSE: BSX) said its Guidant unit will plead guilty to two misdemeanor charges related...

Share this 

What others report on the same story

Boston Sci to pay $296 mln to settle US probe
BOSTONSCIENTIFIC/ (UPDATE 4):UPDATE 4- * Reaches agreement with U.S. DOJ over Guidant advisories* To pay $296 million as part of deal* Will record Q3 charge of $294 ... - [11/06/2009 - Forbes.com]
Boston Sci settles Guidant probe with DOJ
IMS to be bought for $5.2 billion (Nov. 5)RBS posts $3 bln loss as bad-debt charges plateau (8:02a)Story Quotes Comments ScreenerAlertEmail Print By Val Brickates ... - [11/06/2009 - MarketWatch]
Boston Sci Settles Guidant Probe With DOJ - [11/06/2009 - FOXBusiness.com]
Boston Sci settles with feds for $296M - [11/06/2009 - Biz Journals]
1

Related Stories

First Reported 11/06/2009 - Updated 11/07/2009 - 11 Documents
Guidant Corporation - Click to view image in its original context
Guidant Corporation
Boston Scientific reaches agreement with DOJ related to product advisories issued by its Guidant subsidiary
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales ... [News-Medical.Net - 11/07/2009]
First Reported 11/02/2009 - Updated 11/02/2009 - 8 Documents (in Internet & IT)
Boston Scientific Corporation - Click to view image in its original context
Boston Scientific Corporation
Boston Scientific Gets European Approval of Platinum Chromium Promus Stent System
Boston Scientific Corporation Monday announced it hasreceived CE Mark for its PROMUS Element Everolimus-Eluting Coronary Stent System, the Company’sthird-generation drug-eluting stent technology. ... [FDA News - 11/02/2009]
In Focus
Network

Blogs

sort by: Date | Relevance
Boston Scientific Sets $296 Million Settlement ... [WSJ.com: Health Blog - 11/06/2009]
Now you see it. Now you don’t. So it goes with Boston Scientific’s third-quarter profit as a result of a settlement agreement with the Justice Department that the ...
PG&E refutes suit alleging price-gouging vi... [Venturebeat - 11/09/2009]
Pacific Gas & Electric’s smart metering headaches might have just gotten a lot worse. Already, the company has had to fend off accusations that its installation ...
Plasma leaders teamed up to preserve market sha... [The Deal.com - 11/12/2009]
Just-released details from a Federal Trade Commission merger challenge outline the lengths leaders in the market for blood plasma products allegedly took to preserve ...
Plasma leaders teamed up to preserve market sha... [Dealscape - 11/12/2009]
Just-released details from a Federal Trade Commission merger challenge outline the lengths leaders in the market for blood plasma products allegedly took to preserve ...
SEC alleges insider trading at San Francisco fu... [M0 - 10/31/2009]
AP - The Securities and Exchange Commission filed a civil lawsuit alleging insider trading Friday against the former chief financial officer of a San Francisco private ...
1 2 3 4 5 6 7 8 9 10

  •  
  •  
  •